At the news
? NEUTRALIMPACT 4/10 6-K filed Jun 8, 2026 at 08:01 ET
BioNTech announced the commencement of its previously authorized $1.0 billion share buyback program, effective June 8, 2026, through May 6, 2027. The program allows repurchase of up to 24.9 million ADSs (≈10% of share capital) via an independent credit institution, compliant with 10b-18/10b5-1 rules.
- $1.0 billion share buyback program authorized on May 7, 2026, with buyback period June 8, 2026 to May 6, 2027.
- Up to 24.9 million American Depositary Shares (ADSs) may be repurchased, representing approximately 10% of BioNTech's share capital.
- Buyback will be executed by an independent credit institution in compliance with EU MAR and SEC Rules 10b-18 and 10b5-1.
- Repurchased ADSs may be used for ordinary course obligations and to enhance capital efficiency.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access